Quick Answer
LIFECORE BIOMEDICAL, INC. \DE\ reported Diluted EPS of $1.27 per share (loss) for fiscal year 2025.
LIFECORE BIOMEDICAL, INC. \DE\ Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.27 | -484.8% |
| 2024 | $0.33 | +109.9% |
| 2023 | -$3.32 | +16.4% |
| 2022 | -$3.97 | -260.9% |
| 2021 | -$1.10 | +16.0% |
| 2020 | -$1.31 | -13200.0% |
| 2019 | $0.01 | -98.9% |
| 2018 | $0.89 | +134.2% |
| 2017 | $0.38 | +188.4% |
| 2016 | -$0.43 | -186.0% |
| 2015 | $0.50 | -29.6% |
| 2014 | $0.71 | -16.5% |
| 2013 | $0.85 | +73.5% |
| 2012 | $0.49 | +226.7% |
| 2011 | $0.15 | +0.0% |
| 2010 | $0.15 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.29 | — | +38.3% |
| February 28, 2025 | -$0.47 | -211.9% | -88.0% |
| November 30, 2024 | -$0.25 | -164.1% | +52.8% |
| August 31, 2024 | -$0.53 | -51.4% | -226.2% |
| February 29, 2024 | $0.42 | +135.0% | +7.7% |
| November 30, 2023 | $0.39 | +190.7% | +211.4% |
| August 31, 2023 | -$0.35 | +5.4% | +70.8% |
| February 28, 2023 | -$1.20 | -166.7% | -179.1% |
- LIFECORE BIOMEDICAL, INC. \DE\ showed a decrease of -484.8% in Diluted EPS compared to the prior fiscal year.
- Over the 2010–2025 period, LIFECORE BIOMEDICAL, INC. \DE\’s diluted eps has declined by 946.7% (from $0.15 per share to $1.27 per share (loss)).
- The most recent figure is from LIFECORE BIOMEDICAL, INC. \DE\’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 7, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: